Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
- PMID: 23263486
- PMCID: PMC3663712
- DOI: 10.1038/ng.2500
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Abstract
Elevated serum urate concentrations can cause gout, a prevalent and painful inflammatory arthritis. By combining data from >140,000 individuals of European ancestry within the Global Urate Genetics Consortium (GUGC), we identified and replicated 28 genome-wide significant loci in association with serum urate concentrations (18 new regions in or near TRIM46, INHBB, SFMBT1, TMEM171, VEGFA, BAZ1B, PRKAG2, STC1, HNF4G, A1CF, ATXN2, UBE2Q2, IGF1R, NFAT5, MAF, HLF, ACVR1B-ACVRL1 and B3GNT4). Associations for many of the loci were of similar magnitude in individuals of non-European ancestry. We further characterized these loci for associations with gout, transcript expression and the fractional excretion of urate. Network analyses implicate the inhibins-activins signaling pathways and glucose metabolism in systemic urate control. New candidate genes for serum urate concentration highlight the importance of metabolic control of urate production and excretion, which may have implications for the treatment and prevention of gout.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Comment in
-
Genetics: Metabolic pathways newly implicated in gout epidemiology.Nat Rev Rheumatol. 2013 Feb;9(2):64. doi: 10.1038/nrrheum.2013.1. Epub 2013 Jan 15. Nat Rev Rheumatol. 2013. PMID: 23321612 No abstract available.
Similar articles
-
Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.Hum Mol Genet. 2011 Oct 15;20(20):4056-68. doi: 10.1093/hmg/ddr307. Epub 2011 Jul 18. Hum Mol Genet. 2011. PMID: 21768215 Free PMC article.
-
Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control.Hum Mol Genet. 2020 Apr 15;29(6):923-943. doi: 10.1093/hmg/ddaa013. Hum Mol Genet. 2020. PMID: 31985003
-
Effects of multiple genetic loci on the pathogenesis from serum urate to gout.Sci Rep. 2017 Mar 2;7:43614. doi: 10.1038/srep43614. Sci Rep. 2017. PMID: 28252667 Free PMC article.
-
An update on the genetics of hyperuricaemia and gout.Nat Rev Rheumatol. 2018 Jun;14(6):341-353. doi: 10.1038/s41584-018-0004-x. Nat Rev Rheumatol. 2018. PMID: 29740155 Review.
-
The genetic basis of gout.Rheum Dis Clin North Am. 2014 May;40(2):279-90. doi: 10.1016/j.rdc.2014.01.009. Epub 2014 Feb 19. Rheum Dis Clin North Am. 2014. PMID: 24703347 Review.
Cited by
-
Building capacity to conduct genetic epidemiology research on hyperuricaemia and gout in an Indigenous community in Guam.Res Sq [Preprint]. 2024 Feb 22:rs.3.rs-3955100. doi: 10.21203/rs.3.rs-3955100/v1. Res Sq. 2024. PMID: 38464136 Free PMC article. Preprint.
-
Should Glucokinase be Given a Chance in Diabetes Therapeutics? A Clinical-Pharmacological Review of Dorzagliatin and Lessons Learned So Far.Clin Drug Investig. 2024 Mar 9. doi: 10.1007/s40261-024-01351-5. Online ahead of print. Clin Drug Investig. 2024. PMID: 38460077 Review.
-
Serum urate is associated with an increased risk of inflammatory bowel disease: A bidirectional Mendelian randomization study.World J Clin Cases. 2024 Feb 16;12(5):891-902. doi: 10.12998/wjcc.v12.i5.891. World J Clin Cases. 2024. PMID: 38414603 Free PMC article.
-
Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study.Biomedicines. 2024 Jan 27;12(2):300. doi: 10.3390/biomedicines12020300. Biomedicines. 2024. PMID: 38397902 Free PMC article.
-
GWAS-identified hyperuricemia-associated IGF1R variant rs6598541 has a limited role in urate mediated inflammation in human mononuclear cells.Sci Rep. 2024 Feb 12;14(1):3565. doi: 10.1038/s41598-024-53209-7. Sci Rep. 2024. PMID: 38347000 Free PMC article.
References
-
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63:3136–3141. - PubMed
-
- Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002;29:2403–2406. - PubMed
-
- Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31:1582–1587. - PubMed
-
- Yoo HG, et al. Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int. 2011;31:485–491. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P60 DK079637/DK/NIDDK NIH HHS/United States
- N01HC45204/HL/NHLBI NIH HHS/United States
- BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- 12076/CRUK_/Cancer Research UK/United Kingdom
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- MC_U127592696/MRC_/Medical Research Council/United Kingdom
- R01 AA007535/AA/NIAAA NIH HHS/United States
- K12 RR023250/RR/NCRR NIH HHS/United States
- N01AG12100/AG/NIA NIH HHS/United States
- N01 HC095170/HC/NHLBI NIH HHS/United States
- R01 AA014041/AA/NIAAA NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- R01 MH066206/MH/NIMH NIH HHS/United States
- CZB/4/710/CSO_/Chief Scientist Office/United Kingdom
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- R01 AG015928/AG/NIA NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- MC_PC_13041/MRC_/Medical Research Council/United Kingdom
- P01 CA087969/CA/NCI NIH HHS/United States
- P50 AA011998/AA/NIAAA NIH HHS/United States
- N01HC48049/HL/NHLBI NIH HHS/United States
- N01HC45205/HL/NHLBI NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- R01 HL059367/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom
- MR/K006584/1/MRC_/Medical Research Council/United Kingdom
- N01 HC025195/HC/NHLBI NIH HHS/United States
- MC_U127527198/MRC_/Medical Research Council/United Kingdom
- MR/K018647/1/MRC_/Medical Research Council/United Kingdom
- P30 DK079637/DK/NIDDK NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- R01 AA013326/AA/NIAAA NIH HHS/United States
- N01 HC095172/HC/NHLBI NIH HHS/United States
- R01 HL087652/HL/NHLBI NIH HHS/United States
- G0700704/MRC_/Medical Research Council/United Kingdom
- U01 HG004402/HG/NHGRI NIH HHS/United States
- U01 HG004424/HG/NHGRI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- N01HC55222/HL/NHLBI NIH HHS/United States
- P60 AR047785/AR/NIAMS NIH HHS/United States
- N02HL64278/HL/NHLBI NIH HHS/United States
- N01 HC095171/HC/NHLBI NIH HHS/United States
- N01HC85086/HL/NHLBI NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- R01 AA013321/AA/NIAAA NIH HHS/United States
- G1002084/MRC_/Medical Research Council/United Kingdom
- U01 HL084756/HL/NHLBI NIH HHS/United States
- U01 HG004729/HG/NHGRI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- P30 DK072488/DK/NIDDK NIH HHS/United States
- N01HC95095/HL/NHLBI NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- G0600237/MRC_/Medical Research Council/United Kingdom
- R01 AR056291/AR/NIAMS NIH HHS/United States
- R01 HL084099/HL/NHLBI NIH HHS/United States
- N01 HC045134/HC/NHLBI NIH HHS/United States
- G9521010/MRC_/Medical Research Council/United Kingdom
- G1000143/MRC_/Medical Research Council/United Kingdom
- U01 HL072515/HL/NHLBI NIH HHS/United States
- 090532/Wellcome Trust/United Kingdom
- MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom
- R01 HL080295/HL/NHLBI NIH HHS/United States
- R21 AR056042/AR/NIAMS NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- R01 DA012854/DA/NIDA NIH HHS/United States
- MC_PC_U127592696/MRC_/Medical Research Council/United Kingdom
- R01 CA047988/CA/NCI NIH HHS/United States
- N01AG12109/AG/NIA NIH HHS/United States
- R01 AG020098/AG/NIA NIH HHS/United States
- N01HC48050/HL/NHLBI NIH HHS/United States
- 14136/CRUK_/Cancer Research UK/United Kingdom
- N01HC75150/HL/NHLBI NIH HHS/United States
- N01HC05187/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- N01HC48047/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- N01HC85079/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
- Z01 AG000954-06/Intramural NIH HHS/United States
- R01 AG027058/AG/NIA NIH HHS/United States
- MC_U106179471/MRC_/Medical Research Council/United Kingdom
- MC_U106188470/MRC_/Medical Research Council/United Kingdom
- U01 HL069757/HL/NHLBI NIH HHS/United States
- R01 AG018728/AG/NIA NIH HHS/United States
- U01 GM074518/GM/NIGMS NIH HHS/United States
- N01HC48048/HL/NHLBI NIH HHS/United States
- R01 AA013320/AA/NIAAA NIH HHS/United States
- R01 HL088119/HL/NHLBI NIH HHS/United States
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
